ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
The article describes the main anticoagulant drugs used in cancer patients, taking into consideration pathogenetic aspects of hypercoagulation status in cancer patients: oral anticoagulants, heparin drugs, selective inhibitors of Xa factor. The basic advantages of low molecular weight heparin compar...
Main Authors: | A. V. Vorobev, A. M. Chabrov, A. A. Savchenko, A. D. Makatsariya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2016-06-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/33 |
Similar Items
-
Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01) -
The specifics of pathogenetic prevention of thrombotic and hemorrhagic complications in patients with gynecological cancers
by: A. D. Makatsariya, et al.
Published: (2016-12-01) -
Confusing combination of thrombocytopenia and thrombosis after heparin therapy in a patient with cardiac leiomyosarcoma; a nephrologist viewpoint
by: Ardalan Mohammad-Reza
Published: (2014-04-01) -
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational studyResearch in context
by: Henning Nilius, et al.
Published: (2023-01-01) -
Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)